11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
(
- Contribution to journal › Article
- 2008
-
Mark
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
(
- Contribution to journal › Article
-
Mark
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
(
- Contribution to journal › Article
- 2007
-
Mark
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
(
- Contribution to journal › Article
-
Mark
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
- 2004
-
Mark
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.
(
- Contribution to journal › Article
- 2003
-
Mark
Expression profiling to predict outcome in breast cancer: the influence of sample selection
(
- Contribution to journal › Article
- 2002
-
Mark
Bioarray software environment: a platform for comprehensive management and analysis of microarray data
(
- Contribution to journal › Article
- 2001
-
Mark
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
(
- Contribution to journal › Article